Prostate Cancer Treatment Market Size Expected to Reach US$ 10.3 Billion by 2028 | Globally, Growth Rate (CAGR) of 5.8%

 Breaking News
  • No posts were found

Prostate Cancer Treatment Market Size Expected to Reach US$ 10.3 Billion by 2028 | Globally, Growth Rate (CAGR) of 5.8%

February 02
05:59 2023
Prostate Cancer Treatment Market Size Expected to Reach US$ 10.3 Billion by 2028 | Globally, Growth Rate (CAGR) of 5.8%
Prostate Cancer Treatment Market 2023-2028
The global prostate cancer treatment market size reached US$ 7.2 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 10.3 Billion by 2028, exhibiting a growth rate (CAGR) of 5.8% during 2023-2028.

The latest research study “Prostate Cancer Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028” by IMARC Group, finds that the global prostate cancer treatment market size reached US$ 7.2 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 10.3 Billion by 2028, exhibiting a growth rate (CAGR) of 5.8% during 2023-2028.

What is prostate cancer treatment ?

Prostate cancer is a type of severe malignant tumor caused by uncontrollable division and expansion of numerous abnormal cells in the prostate gland. It is diagnosed by clinical laboratory examination, digital rectal exam (DRE), prostate-specific antigen (PSA) test, transrectal ultrasound, transrectal magnetic resonance imaging (MRI), urine testing, and tissue biopsy. It can be treated with numerous therapeutic procedures such as medications, vaccines, and treatments, including immunotherapy, radiation, cryotherapy, surgery, chemotherapy, and biological and hormone therapy, by mitigating the spread of cancer cells in the body. At present, the growing prevalence of prostate cancer is escalating the demand for prostate cancer treatment across the globe.

Download a PDF Sample for more detailed market insights:

Prostate Cancer Treatment Market Trends and Drivers:

The market is primarily driven by the growing instances of prostate cancer, especially amongst the geriatric population. In addition, the rising awareness regarding numerous prostate cancer treatment options is contributing to the market growth.

Moreover, various technological advancements, including the introduction of multiparametric-magnetic resonance imaging (mp-MRI) devices with non-metastatic castration-resistant (nmCRPC) and metastatic hormone nave (mHNPC) settings for diagnosing prostate cancer at early stages, represent another major growth-inducing factor.

Besides this, several governments are taking initiatives to integrate medical reimbursement policies and patient assistance programs (PAPs) that offer financial assistance to patients by providing free medications and treatment, providing a positive thrust to the market growth.

Furthermore, extensive investment in research and development (R&D) activities, mergers and acquisitions, and novel product launches such as PaigeProstate, a clinical-grade artificial intelligence (AI) solution for prostate cancer detection, are creating a favorable market outlook across the globe.

Prostate Cancer Treatment Market Report Scope

Report Coverage


Market size value in 2022

US$ 7.2 Billion

Market forecast in 2028

US$ 10.3 Billion

Growth Rate

CAGR of 5.8% from 2023 to 2028

Base year for estimation


Historical data


Forecast period


Global Prostate Cancer Treatment Market 2023-2028 Analysis and Segmentation: 

Competitive Landscape:

The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.

Prostate Cancer Treatment Companies:

Astellas Pharma Inc. (OTCMKTS: ALPMY)

AstraZeneca plc (NASDAQ: AZN)

Bayer Aktiengesellschaft (OTCMKTS: BAYRY)

Dendreon Pharmaceuticals LLC. (Sanpower Group Co. Ltd.)

F. Hoffmann-La Roche AG

Ferring B.V.

GlaxoSmithKline Plc

Ipsen (Mayroy SA)

Novartis International AG

Takeda Pharmaceutical Company Ltd.

Tolmar Pharmaceuticals Inc.

Explore Report Description with TOC & List of Figure:

The report has segmented the market on the basis of drug type and distribution channel.

Breakup by Drug Type:

  • Chemotherapy
  • Biological Therapy
  • Hormone Therapy
  • Others

Breakup by Distribution Channel:

  • Hospitals Pharmacies
  • Drug Stores and Retail Pharmacies
  • Online Pharmacies

Breakup by Region:

  • North America: (United States, Canada)
  • Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
  • Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
  • Latin America: (Brazil, Mexico, Others)
  • Middle East and Africa

If you want latest primary and secondary data (2023-2028) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.

Key highlights of the report:

  • Market Performance (2017-2022)
  • Market Outlook (2023- 2028)
  • Porter’s Five Forces Analysis
  • Market Drivers and Success Factors
  • SWOT Analysis
  • Value Chain
  • Comprehensive Mapping of the Competitive Landscape

If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

Browse More Trending Industry Research Reports (Book Now With 10% Discount):

Cholera Vaccines Market Report :

Blood Collection Market Report :

Clinical Trial Management Systems Market Report :

Healthcare Cyber Security Market Report :

Intraoral Scanners Market Report :

Medical Tubing Market Report :

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Media Contact
Company Name: IMARC Group
Contact Person: Elena Anderson
Email: Send Email
Phone: +1-631-791-1145
Address:30 N Gould St Ste R
City: Sheridan
State: WY
Country: United States